Study Stopped
COVID-19
Enhancing Exposure Therapy for Post-traumatic Stress Disorder
1 other identifier
interventional
27
1 country
1
Brief Summary
This study is investigating a new brief psychotherapy for post-traumatic stress disorder (PTSD) which, modifies an already proven psychotherapy for PTSD by adding two new components and modifying several others. The goal of the study is to determine whether this experimental treatment outperforms the well-established standard treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Apr 2012
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 3, 2012
CompletedFirst Posted
Study publicly available on registry
April 10, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedAugust 29, 2022
August 1, 2022
7.9 years
April 3, 2012
August 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in PTSD symptom severity
PTSD Symptom Scale - Interview Version
Weeks 6, 10, 22
Secondary Outcomes (4)
Change from baseline in depression symptom severity
Weeks 6, 10, 22.
Change from baseline in trauma-related cognitions
Weeks 6, 10, 22.
Change from baseline in general physical and psychological health
Weeks 6, 10, 22
Change from baseline in work, social/leisure activities, and family/home life functioning
Weeks 6, 10, 22.
Study Arms (3)
Brief Enhanaced Exposure Therapy
EXPERIMENTALThe following interventions are included in this arm: 1. Psycho-education addressing common reactions to trauma 2. Revisiting the Trauma memories 3. Processing the trauma memories 4. In vivo Exposure homework 5. \*Use of a brief pre-exposure trauma memory retrieval trial 6. Exposure to video clips related to the patient's trauma 7. Compound extinction - simultaneously exposing patient to trauma video clips while they listen to their trauma script
Standard Prolonged Exposure Therapy
ACTIVE COMPARATORThe following interventions are included in this arm: 1. Psycho-education addressing common reactions to trauma 2. Revisiting of the Trauma memories 3. Processing the trauma memories 4. Breathing retraining 5. In vivo Exposure homework
Delayed Treatment Control
NO INTERVENTIONPatients assigned to this arm receive assessment only (Week 0, 3, and 6) prior to receiving standard prolonged exposure therapy using the Foa et al treatment manual.
Interventions
Patient engages in repeated revisiting of their trauma memory under the guidance of the therapist for about 40 minutes. During each revisiting trial the patient closes their eyes and verbally describes the trauma and the feeling and thoughts experienced during the trauma.
The patient and therapist discuss the patient's experience during the trauma revisiting with the goal of helping the patient gain alternative perspectives of the trauma.
Through patient handouts and didactic instruction, the patient learns about the common reactions to trauma and the rationale for exposure therapy.
Prior to the start of Imaginal Exposure, the patient is asked to recall a threatening element of their trauma memory for 1 minute. This is followed by a 30-minute rest-period prior to beginning imaginal exposure.
Patient is seated in front of a computer monitor and instructed to view a 30-min looped video clip that thematically resembles the patient's trauma.
Patient is seated comfortably in a chair and instructed to breathe slowly and deeply in a relaxed manner.
Therapist assists the patient in identifying trauma-related situations/activities that the patient is avoiding and encourages the patient to begin to confront these situations between sessions.
The patient repeatedly confronts the truama-related media clip while simultaneously listening to their own trauma script through headphones.
Eligibility Criteria
You may qualify if:
- Current primary PTSD diagnosis based on DSM-IV criteria, with a minimum duration of 12 weeks since the traumatic event.
- Between the age of 18 and 65.
- Medication status stable for at least 6 weeks
You may not qualify if:
- Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as defined by the DSM-IV.
- Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment (i.e., serious suicide risk with intent and plan).
- Current diagnosis of alcohol or substance dependence within the 3 previous months.
- Unwilling or unable to discontinue current trauma-focused psychotherapy.
- Ongoing intimate relationship with the perpetrator (in assault-related PTSD cases).
- Other severe acute or chronic medical or psychiatric condition that, in the judgment of the Medical Director, would make the participant inappropriate for entry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Texas at Austinlead
- University of Pennsylvaniacollaborator
Study Sites (1)
Laboratory for the Study of Anxiety Disorders, University of Texas at Austin
Austin, Texas, 78712, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael J Telch, Ph.D.
University of Texas at Austin
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 3, 2012
First Posted
April 10, 2012
Study Start
April 1, 2012
Primary Completion
March 1, 2020
Study Completion
March 1, 2020
Last Updated
August 29, 2022
Record last verified: 2022-08